Early consolidation with high-dose therapy and autologous stem cell transplantation is a feasible and effective treatment option in HIV-associated non-Hodgkin lymphoma at high risk
暂无分享,去创建一个
A. Levis | C. Almici | U. Tirelli | A. Liberati | M. Spina | A. Bandera | M. Rupolo | P. Tozzi | C. Skert | A. Re | C. Cattaneo | G. Rossi | M. Michieli | A. Liberati | S. Casari | G. Gini | B. Allione | C. Almici | L. Verga | C. Bocci | P. F. Leali | Salvatore Casari | Michele Spina | Umberto Tirelli | Giorgio Rossi | Chiara Cattaneo | Alessandro Re | Alessandro Levis | Alessandra Bandera
[1] M. Chiarini,et al. B- and T-lymphocyte number and function in HIV+/HIV− lymphoma patients treated with high-dose chemotherapy and autologous bone marrow transplantation , 2016, Scientific Reports.
[2] A. Krishnan,et al. Autologous hematopoietic cell transplantation for HIV-related lymphoma: results of the BMT CTN 0803/AMC 071 trial. , 2016, Blood.
[3] W. Wilson,et al. Changes in the influence of lymphoma- and HIV-specific factors on outcomes in AIDS-related non-Hodgkin lymphoma. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.
[4] U. Tirelli,et al. High-dose therapy and autologous peripheral blood stem cell transplantation as salvage treatment for AIDS-related lymphoma: long-term results of the Italian Cooperative Group on AIDS and Tumors (GICAT) study with analysis of prognostic factors. , 2009, Blood.
[5] N. Schmitz,et al. Comparable survival between HIV+ and HIV- non-Hodgkin and Hodgkin lymphoma patients undergoing autologous peripheral blood stem cell transplantation. , 2009, Blood.
[6] P. Biron,et al. Autologous stem-cell transplantation in patients with HIV-related lymphoma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] Min Guan,et al. Anti-HIV drugs for cancer therapeutics: back to the future? , 2009, The Lancet. Oncology.
[8] S. Ibrahim,et al. Regression of HIV-related diffuse large B-cell lymphoma in response to antiviral therapy alone. , 2008, Blood.
[9] A. López-Guillermo,et al. Safety and efficacy of cyclophosphamide, adriamycin, vincristine, prednisone and rituximab in patients with human immunodeficiency virus‐associated diffuse large B‐cell lymphoma: results of a phase II trial , 2008, British journal of haematology.
[10] A. Badley,et al. HIV protease inhibitors impact on apoptosis. , 2008, Medicinal chemistry (Shariqah (United Arab Emirates)).
[11] J. Park,et al. Vascular endothelial growth factor gene polymorphisms and risk of colorectal cancer , 2007 .
[12] T. Witte. Stem Cell transplantation (SCT) for MDS. , 2007 .
[13] C. Gisselbrecht,et al. Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] B. Nathwani,et al. Prognostic factors in HIV-related diffuse large-cell lymphoma: before versus after highly active antiretroviral therapy. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] E. Cesarman,et al. Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010. , 2005, Blood.
[16] A. Nademanee,et al. Autologous stem cell transplantation for HIV-associated lymphoma. , 2001, Blood.
[17] G. Rossi,et al. The International Prognostic Index can be used as a guide to treatment decisions regarding patients with human immunodeficiency virus—related systemic non‐Hodgkin lymphoma , 1999, Cancer.